• English
  • Korean
  • Chinese
表紙
市場調査レポート - 235295

網膜静脈閉塞:世界の治験レビュー

Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013

発行 GlobalData
出版日 ページ情報 英文 217 Pages
価格
網膜静脈閉塞:世界の治験レビュー Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013
出版日: 2013年03月31日 ページ情報: 英文 217 Pages
概要

当レポートでは、世界の網膜静脈閉塞治療薬の臨床試験について調査し、地域別の臨床市件数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 網膜静脈閉塞
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中東およびアフリカ
    • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:主要企業
      • Allergan, Inc.
      • Genentech, Inc.
      • Regeneron Pharmaceuticals, Inc.
      • Okuvision GmbH
      • Mid Atlantic Retina
      • Aleris Helse AS
      • Retina Associates of Cleveland, Inc.
      • Alimera Sciences, Inc.
      • Fovea Pharmaceuticals SA
      • 三和化学研究所
      • Bayer AG
      • Novartis AG
      • 参天製薬
      • Eyetech Pharmaceuticals, Inc.
      • F. Hoffmann-La Roche Ltd.
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • 京都大学
      • Johns Hopkins University
      • Barnes Retina Institute
      • University of Toronto
      • Shaheed Beheshti Medical University
      • Duke University
      • Medical University of Vienna
      • Yonsei University
      • St. Erik Eye Hospital
      • 滋賀医科大学
      • California Retina Consultants
      • Manhattan Eye Ear & Throat Hospital
      • 山形大学医学部附属病院
      • Retina Macula Institute
      • Instituto Universitario de of talmobiologia Aplicada
      • Midwest Eye-Banks
      • Baqiyatallah Medical Sciences University
      • Stavanger University Hospital
      • Shiraz University of Medical Sciences
      • University of Leipzig
  • 5件の主要臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013" provides data on the Retinal Vein Occlusion clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinal Vein Occlusion. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinal Vein Occlusion. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

TOC

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 6
  • Introduction 7
  • Retinal Vein Occlusion 7
  • Report Guidance 7
  • Clinical Trials by Region 8
  • Clinical Trials by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by BRIC Nations 16
  • Clinical Trials by G7 Nations 17
  • Clinical Trials in G7 Nations by Trial Status 18
  • Clinical Trials by E7 Nations 19
  • Clinical Trials in E7 Nations by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Unaccomplished Trials of Retinal Vein Occlusion 24
  • Subjects Recruited Over a Period of Time 27
  • Prominent Sponsors 28
  • Top Companies Participating in Retinal Vein Occlusion Therapeutics Clinical Trials 30
  • Prominent Drug Comparison 32
  • Clinical Trial Profiles 33
  • Clinical Trial Overview of Top Companies 33
  • Allergan, Inc. 33
  • Clinical Trial Overview of Allergan, Inc. 33
  • Novartis AG 34
  • Clinical Trial Overview of Novartis AG 34
  • Genentech, Inc. 35
  • Clinical Trial Overview of Genentech, Inc. 35
  • Novartis Pharmaceuticals Corporation 36
  • Clinical Trial Overview of Novartis Pharmaceuticals Corporation 36
  • Regeneron Pharmaceuticals, Inc. 37
  • Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 37
  • Mid Atlantic Retina 38
  • Clinical Trial Overview of Mid Atlantic Retina 38
  • Chengdu Kanghong Pharmaceuticals Group Co., Ltd. 39
  • Clinical Trial Overview of Chengdu Kanghong Pharmaceuticals Group Co., Ltd. 39
  • Aleris Helse AS 40
  • Clinical Trial Overview of Aleris Helse AS 40
  • Opocrin S.p.A 41
  • Clinical Trial Overview of Opocrin S.p.A 41
  • Retina Associates of Cleveland, Inc. 42
  • Clinical Trial Overview of Retina Associates of Cleveland, Inc. 42
  • Icon Bioscience, Inc. 43
  • Clinical Trial Overview of Icon Bioscience, Inc. 43
  • The EMMES Corporation 44
  • Clinical Trial Overview of The EMMES Corporation 44
  • Alimera Sciences, Inc. 45
  • Clinical Trial Overview of Alimera Sciences, Inc. 45
  • ARCA biopharma, Inc. 46
  • Clinical Trial Overview of ARCA biopharma, Inc. 46
  • Fovea Pharmaceuticals SA 47
  • Clinical Trial Overview of Fovea Pharmaceuticals SA 47
  • Sanwa Kagaku Kenkyusho Co., Ltd. 48
  • Clinical Trial Overview of Sanwa Kagaku Kenkyusho Co., Ltd. 48
  • Bayer AG 49
  • Clinical Trial Overview of Bayer AG 49
  • Santen Pharmaceutical Co., Ltd. 50
  • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 50
  • Eyetech Pharmaceuticals, Inc. 51
  • Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 51
  • Valeant Pharmaceuticals International, Inc. 52
  • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 52
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
  • Shaheed Beheshti Medical University 53
  • Clinical Trial Overview of Shaheed Beheshti Medical University 53
  • Kyoto University 54
  • Clinical Trial Overview of Kyoto University 54
  • Johns Hopkins University 55
  • Clinical Trial Overview of Johns Hopkins University 55
  • University of Toronto 56
  • Clinical Trial Overview of University of Toronto 56
  • Barnes Retina Institute 57
  • Clinical Trial Overview of Barnes Retina Institute 57
  • S:t Eriks Ogonsjukhus AB 58
  • Clinical Trial Overview of S:t Eriks Ogonsjukhus AB 58
  • Shiga University of Medical Science 59
  • Clinical Trial Overview of Shiga University of Medical Science 59
  • Duke University 60
  • Clinical Trial Overview of Duke University 60
  • Medical University of Vienna 61
  • Clinical Trial Overview of Medical University of Vienna 61
  • Ludwig-Maximilians-Universitat Munich 62
  • Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 62
  • California Retina Consultants 63
  • Clinical Trial Overview of California Retina Consultants 63
  • Asociacion para Evitar la Ceguera en Mexico I.A.P. 64
  • Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 64
  • Manhattan Eye Ear & Throat Hospital 65
  • Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital 65
  • Yamagata University Hospital 66
  • Clinical Trial Overview of Yamagata University Hospital 66
  • Keio University Hospital 67
  • Clinical Trial Overview of Keio University Hospital 67
  • Stavanger University Hospital 68
  • Clinical Trial Overview of Stavanger University Hospital 68
  • The University of Chicago 69
  • Clinical Trial Overview of The University of Chicago 69
  • Shiraz University of Medical Sciences 70
  • Clinical Trial Overview of Shiraz University of Medical Sciences 70
  • Hospital Universitario Ramon y Cajal 71
  • Clinical Trial Overview of Hospital Universitario Ramon y Cajal 71
  • The Medical University of Graz 72
  • Clinical Trial Overview of The Medical University of Graz 72
  • Five Key Clinical Profiles 73

Appendix 214

  • Abbreviations 214
  • Definitions 214
  • Research Methodology 215
  • Secondary Research 216
  • About GlobalData 216
  • Contact Us 216
  • Disclaimer 216
  • Source 217

List of Tables

List of Tables

  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
  • Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 14
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
  • Retinal Vein Occlusion Therapeutics Clinical Trials, BRIC Countries, 2013* 16
  • Retinal Vein Occlusion Therapeutics Clinical Trials, G7 Countries, 2013* 17
  • Retinal Vein Occlusion Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
  • Retinal Vein Occlusion Therapeutics Clinical Trials, E7 Countries, 2013* 19
  • Retinal Vein Occlusion Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
  • Retinal Vein Occlusion Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
  • Retinal Vein Occlusion Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
  • Retinal Vein Occlusion Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 33
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 34
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2013* 35
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2013* 36
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2013* 37
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Mid Atlantic Retina, 2013* 38
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu Kanghong Pharmaceuticals Group Co., Ltd., 2013* 39
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Aleris Helse AS, 2013* 40
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Opocrin S.p.A, 2013* 41
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Associates of Cleveland, Inc., 2013* 42
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Icon Bioscience, Inc., 2013* 43
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The EMMES Corporation, 2013* 44
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Alimera Sciences, Inc., 2013* 45
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCA biopharma, Inc., 2013* 46
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Fovea Pharmaceuticals SA, 2013* 47
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanwa Kagaku Kenkyusho Co., Ltd., 2013* 48
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 49
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2013* 50
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2013* 51
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2013* 52
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaheed Beheshti Medical University, 2013* 53
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013* 54
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 55
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013* 56
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2013* 57
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by S:t Eriks Ogonsjukhus AB, 2013* 58
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiga University of Medical Science, 2013* 59
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 60
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 61
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2013* 62
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by California Retina Consultants, 2013* 63
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2013* 64
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2013* 65
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Yamagata University Hospital, 2013* 66
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University Hospital, 2013* 67
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Stavanger University Hospital, 2013* 68
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 69
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2013* 70
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Ramon y Cajal, 2013* 71
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 72

List of Figures

List of Figures

  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
  • Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 14
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
  • Retinal Vein Occlusion Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
  • Retinal Vein Occlusion Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
  • Retinal Vein Occlusion Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
  • Retinal Vein Occlusion Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
  • Retinal Vein Occlusion Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • GlobalData Methodology 215
Back to Top